Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.
On Saturday, November 16, the Columbia University Department of Surgery hosted Lung Cancer Awareness Day at the medical center campus, in Washington Heights.
In August 2013, a large study published in the Journal of the National Cancer Institute found that following a high quality diet may help to reduce one’s risk for developing pancreatic cancer.
Utilizing the latest techniques in molecular biology and genetics, the married team of Cory Abate-Shen and Michael Shen are tackling metastatic prostate cancer.
Radiation exposure from breast cancer treatment is associated with a small risk of developing heart disease later in life, but the risk is now lower than it was 20 years ago.